IMS Flashcards
Pataus
Trisomy 14 - affects midline structures, cleft lip, incomplete brain, congenital heart disease
Klinefelters
47XXY
Infertility and poorly developed secondary characteristics as lacks testosterone
Turners
45XO
99% Still born
Short in stature, primary amenorrhea, congenital heart disease, puffy feet, redundant skin at back of neck
William Beurens
26 genes deleted from q arm of chromosome 7
Bright eyes, wide mouth, upturned nose, heart defect
Digeorge/Velocardiofacial Syndrome
Section deleted from chromosome 22
Small mouth, prominent nose, heart defects
Edward’s Syndrome
Trisomy 18 - clenched hands, overlapping fingers, multiple malformations
Duchenne Muscular Dystrophy
X-linked recessive
Absence of dystrophin, invasion of fibrous tissue
Stands using Gavet’s manoeuvre
Lever Hereditary Optic Neuropathy
Reduced vision and hyperarray of disc
Genetic Imprinting
Marks on chromosomes show if maternal or paternal
Change in message doesn’t show the origin hence can cause problems
Familial Hyperchilesterolaemia
Austomal Dominant
Can be caused by over 150 different mutations
If cholesterol is over 7.5mmol suspect the disease
Lipoprotein A may also be raised
Treat with lifestyle and statins
Macrophages release…
TNF and IL-2
MHC Class I are on…
All cells
Th helper cell cytokines
Th1 - IL-2, IL-5
Th2 - IL-13, IL-16
Myasthenia Gravis
May be due to thyroid tumour causing excess antibodies attacking receptors
Blurred vision, fatigue, decline in fitness
Relieved by edrophoneum, neostigme treats it
CMAP decreases each time due to muscle fatigue!
What chiefly carries cholesterol in ester form
LDL
Statins are…
HMG CoA Reductase Inhibitors
Prenylation
Adds small lipid tail to small G proteins to anchor them to the membrane
Rho
Prenylated by… regulates the cell cytoskeleton
MRSA
Chlorineepexidene wash , isolate for 5 days
Downs Syndrome
Trisomy 21 is the most common
Suspect Robertsonoan if high number of miscarriages in family history
Differences between transcription in prokaryotes and eukaryotes
1) nucleus in eukaryotes
2) modification in eukaryotes
3) more than one RNA polymerase in eukaryotes
Post transcriptional modifications
5’ end capped with 7 methyl guanine - looks like functional 3’ end
3’ end cleaved and polyA tail added
Splicing
RNA transcription error rate
10^4
Similarities/differences between DNA and RNA polymerase
Similarities: both form chain in 5’ to 3’, both form phosphidesater bonds, both use template strand
Differences: DNA polymerase needs a primer, need a free OH group for DNA, DNA adds deoxy nucleotides
DNA primate
makes RNA primers for DNA replication
Base/nucleotide excision
Repairs to 10^9!
Sickle Cell Anaemi
GAG->GAT 17th nucleotide Glutamic acid –> Hydrophobic valine
sickle cell crisis lasts 5 to 7 days
RBCS die after about 10/20 days
Creative
CKMM in muscle, CKMB in heart
CK peaks 12 hours after myocardial infarction
ADH and AldDh
Japanese people have efficient ADH, inefficient ALDH due to inactivity of mitochondrial and toxic enYmes of this
Ecstasy
Reverts the serotonin SERR transporter to work in the opposite directions!
Often hyponytraemia, hypokalkuraemia, low chloride due to over drinking
Hyponytraemia
Low blood sodium, can cause swelling due to uptake of water by tissues
Erections
NO stimulates guanyl Cyclase
cGMP, stimulates PKG, causes smooth muscles relaxation and dilation, causes erection
Viagra inhibits PDE5
Ginseng stimulates Nos to make NO
Therapeutic Index
Toxic drug dosage:Therapeutic dose
penicillin stable in acid
G unstable
V stable
migraine
gastric stasis
Gentamicin
confined to body fluids whereas vancomycin treats c. diff as not absorbed by G proteins
Digoxin and erythromycin interact
gut bacteria usually inactivate digoxin, erythromycin kills this bacteria, less digoxin inactivated hence more drug absorbed
Ethinylesteadiol hepatic re circulation
Liver to vile to gut to liver, causes two 2 peaks so the antibiotics can prevent the ethinylestradiol from working
Cockcroft Gault equation
Estimates creative clearance = (140-age) x kg x constant all divided by serum creative
Enzyme inducing drug
phenytoin
enzyme inhibiting drug
erythromycin
H1 receptors
Mainly in mucous membranes
If you block causes drowsiness
Most H1 antagonists have anti cholinergic properties
H2 receptors
cause acid production
alpha adrenergic receptors
In blood vessels
Beta adrenergic receptors
beta 1 in heart
beta 2 in bronchioles
Propanol ok
blocks beta 1 and 2 equally
Atenolol
Blocks beta 1 more than beta 2 but avoid in asthma
Insulin mechanism
binds to alpha subunit, enters cell insulin destroyed, beta subunit activates the tyrosine kinase
NSAIDS
Aspirin and ibuprofen are non specific
It is COX 2 that causes inflammation
Ramipril
ACE inhibitor
MAOIs
prevent breakdown of neurotransmitters in synaptic cleft hence treats depression
Local anaesthetics information
Charged hydrophilic amine group and lipid soluble hydrophilic aromatic group
Either Amide or Esther bond between them
Amide more common, stable, hypersensitive rare, more likely to be toxic, metabolised by lived, ionised at physiological ph
Ester rapidly hydrolysed by plasma esterases, produce PABA causing hypersensitivity!
Local anaesthetics mode of action
1) diffuser through lipophilic nerve membrane unionised
2) low pH in cell ionises them, they then blocks Na channels and then impulses can’t pass
Can also cause myocardial depression and vasodilation
Cocaine causes vasoconstriction
Adrenaline given to cause vasoconstriction to prolong effect as it lessens distribution but don’t use in extremities
beta lactam antibiotics
inhibit cell wall synthesis, eg penicillin
macrolides
inhibit bacterial cell wall synthesis e.g. erythromycin
anti fungal a
Inhibited ergesterole in fungal cell membrane e.g. nyastin
Antihelminths
Ascarides treat worms by paralysing effect on the CNS
Nicotinic receptors
post synaptically at all autonomic ganglia and neuromuscular junctions
muscarinic
post synaptically at parasympathetic neuroeffector junction and at sympathetic sweat glands
5 Types
M1,3,5 activate phospholipase C
M2 in heart to reduce cAMP and reduce heart rate
M4 reduces cAMP this and M2 are negatively couples to adenyl Cyclase
Tyrosine forms
NA and ACh
Alpha adrenergic receptors
NA>Adrenaline>Isoprenaline
Beta adrenergic receptors
Isoprenaline>Adrenaline>Noradrenaline
Alpha 1 adrenergic receptor
vasoconstriction, activates phospholipase C
alpha 2 adrenergic receptor
inhibits adenylate Cyclase, inhibits neurotransmitter release
beta 1 adrenergic receptor
increases cardiac rate and force
beta 2 adrenergic receptor
bronchodilator and vasodilator
beta 3 adrenergic receptor
lipolysis
Alpha 1 antagonist
phenylenephrine
alpha 2 antagonist
clonindine
beta 1 agonist
dobutamine
beta 2 agonist
salbutamol
beta 1/2 antagonist
propnalol and atenolol (atenolol blocks 1 more than 2)
Beta blocker effects
cold extremities, bronchoconstriction, depression, bradychardia
A2B3 Platelet receptor
Aggregation
A2B1, GPV1
Adhesion –> binds collagen
CP1b/IX/V, PAR-1, TP, P2Y12
Activation –> binds thrombin
Thrombaxane in platelets
Used for auto activation, made by COX-1 and TX Synthase
Platelet alpha granules contain
fibrinogen, FV, vWF
Dense granules
Release ADP - an autocrine molecule, thromboxane is also an autocrine molecule
Sequence of blood clotting with platelets
Endothelial damage –> collagen exposed so binds to A2B1 and GPV1
Activated platelets release ADP and thromboxane, binds to P2Y12 and TP to activate others
A2B3 binds fibrinogen along with vWF holding the clot together
Clopidogrel, trigrelor, prasugel
ADP receptor inhibitors on platelets
Vitamin K Dependent clotting factors
II, VII, IX, X
Serine Proteases
VII, IX, X XI, thrombin
Extrinsic Pathway
Triggered by trauma, causes the initial coagulation
Intrinsic pathway
Consolidates thrombin generation, due to damaged surfaces
Platelet life span
5-9 days
Main trigger for coagulation
Tissue factor is the main trigger for coagulation, it is found on the surface of all perivascular cells and auto activates FVII when bound
Thrombin helps to activate which other factors
FXI, VIII, XIII (shows FXII has an almost irrelevant part in the clotting cascade as thrombin can activate FXI anyway)
T-lymphotrophic virus HTLV1 is associated with what disease
leukaemia
Leaukaemia
WBC’s accumulate in blood causing bone marrow failure
Initially decreased RBC’s and platelets but high WBCs, then WBC’s also decrease
Hyper viscosity of blood due to high WBC count causes respiratory, neurological problems, tiredness, bleeding and bone pain.
Reed-Sternberg cells characterise what
Originate from B lymphocytes in Hodgkins lymphoma
Iron defeciency anaemia
Microcytic anaemia, reduced Hb production
Vit B12/folate defeciency
Macrocytic anaemia, macroavolocytes also form which causes hyperhsegmented neutrophils
It is also needed for DNA replication
Normocytic Anaemia
Caused due to blood loss
Kidney Failure Anaemia
Expo (erythropoeitin) is secreted by kidneys and needed for erythropoiesis, treat with rEPO
Haemolytic Anaemia
Reduces RBC lifespan from 120 days to just 20
Acquired Anaemias
Immune –> haemolytic disease of the newborn
Non-immune –> snake bites, malaria, septicaemia, drugs, mechanical e.g. heart valves
Inherited Anaemias
Virtually all inherited anaemias are haemolytic
Spherocytosis –> mutation in alpha or beta spectrin in cell cytokskeleton
RBC enzyme defects –> e.g. glucose-6-dehydrogenase deficiency meaning the RBC lacks NADH
Haemoglobin defects
Sickle Cell Anaemia
Glutamic acid –> Hydrophobic Valine, causes sickling of RBC that can block microvasculature
Thalassaemias
Deletion of large sections of the alpha globin in haemoglobin
Beta thalassaemia
Point mutation in the beta globin gene, if both genes are affected then the patient has HbF and thalassaemia major
What is blood serum
Plasma without the clotting factors
Blood and plasma donors
O is the universal blood donor, AB is the universal plasma donor
Rhesus blood group
Based on a D antigen on transmembrane proteins in RBCs
Haemolytic disease of the newborn –> Rh- mother and Rh+ baby sensitisation occurs if previous pregnancy occurred
Treated with RhIgG at 28, 34 week and within 72 hours of delivery!
Hormones causing vasoconstriction
Thromboxane (from activated platelets)
Serotonin (from activated platelets)
Angiotensin (from liver precursor)
Vasopressin/ADH (from pituitary gland)
Primary haemostasis
Platelet aggregation and activation
Secondary haemostasis
Clotting cascade producing the fibrin clot
Abdominal Aortic Aneurysm
Normal aorta is 2-3cm, anything over 5cm is inoperable
Disseminated Intravascular Conjugation
Infection which leads to Sepsis
TF is expressed by WBC’s activating factor 7 leading to systemic coagulation causing clots
Clotting factors are all used up hence bleeding occurs
Clotting and bleeding occurring at the same time causing multiple organ failure
Vitamin K Dependent Factos
Factors 2, 7, 9, 10, proteins C & S
These undergo a post transcriptional modification of glutamic acid to gamma-carboxyglutamic acid - Gla then binds to -vely charged phospholipids provided by activated platelets via Ca2+
Vitamin K–> KH2–>Epoxide (KO) it is this last step which converts Glu to Gla
KO then converted back to vitamin K
VKOR Inhibitors
E.g. Warfarin, prevent the conversion of epoxide back to vitamin K hence prevents clotting as vitamin K dependent clotting factors aren’t produced
Vitamin K Defeciency due to…
Malbsorption, liver disease, drugs, bleeding
Haemophilia A
Factor VIII defeciency
X-linked recessive
No consolidation of blood clot –> may need treatment with recombinant or plasma concentrates.
Haemophilia B
Factor IX Defeciency, Christmas Disease
For treatment of both haemophilias need recombinant or plasma concentrates of FVIII/FIX, but may develop immune resistance to them hence give immunosuppressants
Prothrombin Time
TF trigger, measure the extrinsic pathway! Prolonged clotting time in FVII defeciency
Activated Portal Thrombo-plastin (APPT)
Prolonged clotting time if deficiency in intrinsic pathway i.e. Factors XII, XI, IX, VII defeciency
PT Normal, Prolonged APTT
Haemophilia
vWF
vWF multiglomeric protein produced by Weibel Palade bodies in endothelial cells and alpha granules in platelets
Stabilises FVII and involved in platelet adhesion and aggregation
vWF Disease
Type 1 - heterozygous - autosomal dominant - mild
Type 2 - functionl - autosomal recessive - mild
Type 3 - complete deficiency - autsomal recessive - severe
Platelet Type - mutation in GPVI affects adhesion/aggregation
Symptoms: menorhaggia, nose bleeds, GI bleeds, petechia, joint or muscular pain
Thrombocytopaenia/thrombobasthenia
Acquired: Leukaemia, DIC, Immume thomobcytopenic Propura
Inherited: Congentital amegakaryotic thrombocytopoenia, Farconis Anaemia, Glanzmann (A2B3 mutation) or Bernard Souilleir (GPVI defeciecny)
Symptoms:Haemophilia symptoms but milder
Treatment: Underlying cause, steroids for ITP, platelet transfusion
Bernard Souillier
GPVI defeciency
Glanzmann
A2B3 mutation
DVT
Low blood flow and pressure, in valves of legs –> can cause PE
Thrombus is fibrin and erythrocyte rich!
Risk factors: immobilisation, genetics, pregnancy, cancer (cells express TF), surgery
Treatment: IV Unfractioned Heparin (helps antithrombin)
Slow onset: Warfarin and coumarins, direct thrombin inhibitors e.g. Dabigatran
Virchows Traingle
1) Change in endothelial state/injury
2) Hypercoagulative state
3) Circulatory status
Dabigatran
Direct thrombin inhibitor
Oral tablet that doesnt need monitoring!
Antithrombin
Natural anti-coagulant
Inhibits FIX and X
Stimulated by Heparin
TF Pathway Inhibitor
Natural anti-coagulant
Inhibits FXII/TF & X
Protein C
Natural anti-coagulant
Proteolytically activates FVa and VIIIa
Protein S
Natural anti-coagulant
Cofactor for protein C
Factor V Leiden
Arg-Glu mutation. activated Protein C usually cleaves FVa at 3 peptide bonds to inactivate
Mutation stops the cleavage, coagulation can still occur
Fibrolysis
Fibrin enhances plasminogen to be converted to plasmin. Plasmin degrades the fibrin clot
tPA and UPA activate plasminogen
PAI-I blocks the tPA and UPA active sites
TAF1 blocks enhancement
Atherosclerosis
Inflammation of vessel wall –> macrophages either the subintimal space and turned into foam cells, black rupture, collagen exposed binds A2B1 and GPV1, clotting occurs
Lysophosphatidic Acid (LPA)
Activates platelets via P2Y12
Arterial clotting
Thrombus is platelet rich
Treatment: Antiplatelets Aspirin Statins - lower cholesterol Abciximab, tirofiban - anti A2B3 Clopidogrel - anti P2Y12 Fibrinolytic tPA and UPA
Aspirin
COX Inhibitor –> Stops inflammation but also stops production of thromboxane hence prevent platelet activation